Pediatric Nephrology Section, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Pediatric Service, Complejo Hospitalario Universitario de Canarias, Santa Cruz de Tenerife, Spain.
Eur J Pediatr. 2019 Apr;178(4):525-531. doi: 10.1007/s00431-019-03324-9. Epub 2019 Jan 31.
Severe (grades IV and V) vesicoureteral reflux (VUR) is a risk factor for acute pyelonephritis, renal scars, and renal failure. This study evaluates albumin and N-acetylglucosaminidase (NAG) urinary excretion, and renal concentrating ability as screening tools to select patients for voiding cystourethrogram (VCUG). Children (111 M, 52 F) aged 10.97 ± 21.17 months (mean + SD), diagnosed with UTI, and who had undergone renal ultrasound and a VCUG, underwent a desmopressin test and had albumin/creatinine and NAG/creatinine urinary excretion measured. Urine osmolality was significantly lower in 27 children with severe VUR (375.3 ± 171.8 mOsm/kg; mean + SD) compared to 100 patients with normal VCUG (611.5 ± 175.8 mOsm/kg), p < 0.001, and to 36 patients with VUR grades I to III (636.2 ± 180.2 mOsm/kg), p < 0.001. NAG/creatinine ratio was significantly elevated in 20 children with severe VUR (26.4 (28.3) U/g); median and interquartile range compared to 67 children with normal VCUG (10.8 (17.9) U/g), p = 0.003, and to 20 patients with VUR grades I to III (7.6 (21.1) U/g), p = 0.009.Conclusions: Urinary osmolality is significantly decreased and urinary excretion of NAG is significantly increased in patients with severe VUR. These tests could select patients for VCUG to assess for severe VUR. What is Known: • Severe vesicoureteral reflux (SVUR) may contribute to renal damage. Severe vesicoureteral reflux is diagnosed by voiding cystourethrogram and represents about 10% of all patients with VUR. Currently, there are no reliable tests used prior to VCUG to help on the decision of obtaining a VCUG to diagnose SVUR. What is New: • This study shows that renal tubular markers (concentrating ability and N-acetylglucosaminidase (NAG) excretion) are useful tests prior to voiding cystourethrogram to screen for severe vesicoureteral reflux. • This study suggests the use of renal concentrating ability and urinary N-acetylglucosaminidase (NAG) excretion to screen for severe vesicoureteral reflux before requesting a voiding cystourethrogram.
严重(IV 级和 V 级)膀胱输尿管反流(VUR)是急性肾盂肾炎、肾瘢痕和肾衰竭的危险因素。本研究评估白蛋白和 N-乙酰葡萄糖胺酶(NAG)尿排泄以及肾脏浓缩能力作为筛选工具,以选择接受排尿性膀胱尿道造影(VCUG)的患者。
10.97±21.17 个月(均值+标准差)的患有尿路感染的 111 名男性(M)和 52 名女性(F)儿童,进行了肾脏超声和 VCUG 检查,然后进行了去氨加压素试验,并测量了白蛋白/肌酐和 NAG/肌酐尿排泄。
27 名严重 VUR 患儿的尿渗透压明显低于 100 名 VCUG 正常患儿(611.5±175.8 mOsm/kg),p<0.001,也低于 36 名 VUR 分级 I 至 III 级患儿(636.2±180.2 mOsm/kg),p<0.001。20 名严重 VUR 患儿的 NAG/肌酐比值明显升高(26.4(28.3)U/g),中位数和四分位距与 67 名 VCUG 正常患儿(10.8(17.9)U/g)相比,p=0.003,与 20 名 VUR 分级 I 至 III 级患儿(7.6(21.1)U/g)相比,p=0.009。
严重 VUR 患儿的尿渗透压明显降低,NAG 尿排泄明显增加。这些检测可以选择患者进行 VCUG 以评估严重 VUR。
•严重膀胱输尿管反流(SVUR)可能导致肾脏损伤。严重膀胱输尿管反流通过排尿性膀胱尿道造影诊断,约占所有 VUR 患者的 10%。目前,在进行 VCUG 以诊断 SVUR 之前,没有可靠的检测方法可用于帮助决定是否进行 VCUG。
•本研究表明,肾小管标志物(浓缩能力和 N-乙酰葡萄糖胺酶(NAG)排泄)是在排尿性膀胱尿道造影之前筛选严重膀胱输尿管反流的有用检测。
•本研究建议在要求进行排尿性膀胱尿道造影之前,使用肾脏浓缩能力和尿 N-乙酰葡萄糖胺酶(NAG)排泄来筛选严重膀胱输尿管反流。